Using the online tool KM Plotter, we see that TBX2 mRNA expression (as evaluated using 4 different probesets) correlated (significantly in most instances) with poor outcomes in ERα breast cancers and within the Triple Negative Breast Cancer (TNBC) subtype (Supplementary Figure S12). The gene discussed is TBX2; the disease is triple-negative breast carcinoma.